The geographic distribution of liver cancer in Canada does not associate with cyanobacterial toxin exposure

International Journal of Environmental Research and Public Health

Volumn 12, Issue 12, 2015, Pages 15143-15153

  Labine, Meaghan A ^a   Green, Chris ^a   Mak, Giselle ^a   Xue, Lin ^a   Nowatzki, Janet ^a   Griffith, Jane ^a   Minuk, Gerald Y ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Blue green algae; Cyanobacteria; Cyanotoxins; Eutrophication; Hepatitis B; Hepatitis C; Liver cancer; Microcystin

Indexed keywords

BACTERIAL TOXIN; FRESH WATER; CYANOBACTERIAL TOXIN; MARINE TOXIN; MICROCYSTIN;

CANCER; CYANOBACTERIUM; DISEASE INCIDENCE; EUTROPHICATION; GEOGRAPHICAL DISTRIBUTION; HEPATITIS; LAKE POLLUTION; MEDICAL GEOGRAPHY; RISK FACTOR; TOXIN;

ARTICLE; BACTERIUM CONTAMINATION; CANADA; CONTROLLED STUDY; ENVIRONMENTAL MONITORING; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HUMAN; IMMIGRANT; INCIDENCE; INFECTION RISK; LIVER CANCER; PREDICTION; RISK ASSESSMENT; URBAN AREA; ADULT; AGE; AGED; CHEMISTRY; COMPARATIVE STUDY; CYANOBACTERIUM; ENVIRONMENTAL EXPOSURE; EUTROPHICATION; FEMALE; LAKE; LIVER NEOPLASMS; MALE; MICROBIOLOGY; MIDDLE AGED; MIGRANT; PREVALENCE; REGRESSION ANALYSIS; RURAL POPULATION; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; VERY ELDERLY;

CANADA;

CHLOROPHYTA; CYANOBACTERIA; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTERIAL TOXINS; CANADA; CYANOBACTERIA; EMIGRANTS AND IMMIGRANTS; ENVIRONMENTAL EXPOSURE; EUTROPHICATION; FEMALE; HEPATITIS B; HUMANS; INCIDENCE; LAKES; LIVER NEOPLASMS; MALE; MARINE TOXINS; MICROCYSTINS; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; RURAL POPULATION; SEX FACTORS; URBAN POPULATION;

EID: 84949309159     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph121214969     Document Type: Article

References (47)

1. Pocobelli, G.; Cook, L.S.; Brant, R.; Lee, S.S. Hepatocellular carcinoma incidence trends in Canada: Analysis by birth cohort and period of diagnosis. Liver Int. 2008, 28, 1272–1279.[CrossRef][PubMed]
2. Canadian Cancer Society Steering Committee. Canadian Cancer Statistics: 2010; Canadian Cancer Society: Toronto, ON, Canada, 2010.
3. Marrett, L.D.; De, P.; Airia, P.; Dryer, D. Cancer in Canada in 2008. CMAJ 2008, 179, 1163–1170.[CrossRef][PubMed]
4. Public Health Agency of Canada. Cancer Surveillance On-Line 2009. Available online: http://dsol-smed.phac-aspc.gc.ca/dsol-smed/cancer/c_prv-eng.php (accessed on 17 April 2011).
5. Dyer, Z.; Peltekian, K.; van Zanten, S.V. Review article: The changing epidemiology of hepatocellular carcinoma in Canada. Aliment. Pharmacol. Ther. 2005, 22, 17–22.[CrossRef][PubMed]
6. Farazi, P.A.; DePinho, R.A. Hepatocellular carcinoma pathogenesis: From genes to environment. Nat. Rev. Cancer 2006, 6, 674–687.[CrossRef][PubMed]
7. Wong, R.; Corley, D.A. Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am. J. Med. 2008, 121, 525–531.[CrossRef][PubMed]
8. Kulkarni, K.; Barcak, E.; El-Serag, H.; Goodgame, R. The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States. Aliment. Pharmacol. Ther. 2004, 20, 445–450.[CrossRef][PubMed]
9. Walter, S.R.; Thein, H.H.; Gidding, H.F.; Amin, J.; Law, M.G.; George, J.; Dore, G.J. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or hepatitis C. J. Gastroenterol. Hepatol. 2011, 26, 1757–1764.[CrossRef][PubMed]
10. Cabibbo, G.; Craxi, A. Epidemiology, risk factors and surveillance of hepatocellular carcinoma. Eur. Rev. Med. Pharmacol. Sci. 2010, 14, 352–355.[PubMed]
11. Loomba, R.; Yang, H.I.; Su, J.; Brenner, D.; Iloeje, U.; Chen, C.J. Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men. Clin. Gastroenterol. Hepatol. 2010, 8, 891–898.[CrossRef][PubMed]
12. Balbi, M.; Donadon, V.; Ghersetti, M.; Grazioli, S.; Valentina, G.D.; Gardenal, R.; Dal Mas, M.; Casarin, P.; Zanette, G.; Miranda, C. Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy. Int. J. Environ. Res. Public Health 2010, 7, 1366–1378.[CrossRef][PubMed]
13. Del Gaudio, A.; Boschi, L.; Del Gaudio, G.A.; Mastrangelo, L.; Munari, D. Liver damage in obese patients. Obes. Surg. 2002, 12, 802–804.[CrossRef][PubMed]
14. Carmichael, W.W. Cyanobacteria secondary metabolites—The cyanotoxins. J. Appl. Bacteriol. 1992, 72, 445–459.[CrossRef][PubMed]
15. Puschner, B.; Galey, F.D.; Johnson, B.; Dickie, C.W.; Vondy, M.; Francis, T.; Holstege, D.M. Blue-green algae toxicosis in cattle. J. Am. Vet. Med. Assoc. 1998, 213, 1605–1607.[PubMed]
16. Chorus, I.; Bartram, J. Toxic Cyanobacteria in Water: A Guide to Their Public Health Consequences, Monitoring and Management; E & FN Spon: London, UK, 1999.
17. Jacoby, J.M.; Collier, D.C.; Welch, E.B.; Crayton, M. Environmental factors associated with a toxic bloom of Microcystis aeruginosa. Can. J. Fish. Aquat. Sci. 2000, 57, 231–240.[CrossRef]
18. Kotak, B.G.; Zurawell, R.W.; Prepas, E.E.; Holmes, C.F.B. Microcystin-LR concentration in aquatic food web compartments from lakes of varying trophic status. Can. J. Fish. Aquat. Sci. 1996, 53, 1974–1985.[CrossRef]
19. Paerl, H.W.; Fulton, R.S., 3rd; Moisander, P.H.; Dyble, J. Harmful freshwater algal blooms, with an emphasis on cyanobacteria. Sci. World J. 2001, 1, 76–113.[CrossRef][PubMed]
20. Hudnell, K.H.; Paerl, H. Nutrient and other environmental controls of harmful cyanobacterial blooms along freshwater-marine continum. In Cyanobacterial Harmful Algal Blooms: State of the Science and Research Needs; Springer Science: New York, NY, USA, 2008; Volume 619.
21. Health Canada. Blue-Green Algae (Cyanobacteria) and their Toxins 2008. Available online: http://www.hc-sc.gc.ca/ewh-semt/pubs/water-eau/cyanobacter-eng.php (accessed on 17 April 2011).
22. Hudnell, K.H. Cyanobacterial harmful algal blooms: State of the science and research needs. In Advances in Experimental Medicine and Biology; Back, N.C., Ligtha, I.R., Lambris, A., Paoletti, J.D., Eds.; Springer: Berlin, Germany, 2008; pp. 217–238, 239–258, 259–274.
23. Carmichael, W.W. Health effects of toxin-producing cyanobacteria: “The CyanoHABs”. Hum. Ecol. Risk Assess. 2001, 7, 1393–1407.[CrossRef]
24. Poste, A.E.; Hecky, R.E.; Guildford, S.J. Evaluating microcystin exposure risk through fish consumption. Environ. Sci. Technol. 2011, 45, 5806–5811.[CrossRef][PubMed]
25. Duy, T.N.; Lam, P.K.; Shaw, G.R.; Connell, D.W. Toxicology and risk assessment of freshwater cyanobacterial (blue-green algal) toxins in water. Rev. Environ. Contam. Toxicol. 2000, 163, 113–185.[PubMed]
26. Gan, N.; Sun, X.; Song, L. Activation of Nrf2 by microcystin-LR provides advantages for liver cancer cell growth. Chem. Res. Toxicol. 2010, 23, 1477–1484.[CrossRef][PubMed]
27. Dias, E.; Matos, P.; Pereira, P.; Batoréu, M.C.; Silva, M.J.; Jordan, P. Microcystin-LR activates the ERK1/2 kinases and stimulates the proliferation of the monkey kidney-derived cell line Vero-E6. Toxicol. In Vitro 2010, 24, 1689–1695.[CrossRef][PubMed]
28. Zegura, B.; Lah, T.T.; Filipic, M. The role of reactive oxygen species in microcystin-LR-induced DNA damage. Toxicology 2004, 200, 59–68.[PubMed]
29. Ohta, T.; Nishiwaki, R.; Yatsunami, J.; Komori, A.; Suganuma, M.; Fujiki, H. Hyperphosphorylation of cytokeratins 8 and 18 by microcystin-LR, a new liver tumor promoter, in primary cultured rat hepatocytes. Carcinogenesis 1992, 13, 2443–2447.[CrossRef][PubMed]
30. Monks, N.R.; Liu, S.; Xu, Y.; Yu, H.; Bendelow, A.S.; Moscow, J.A. Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cells. Mol. Cancer Ther. 2007, 6, 587–598.[CrossRef][PubMed]
31. Solter, P.F.; Wollenberg, G.K.; Huang, X.; Chu, F.S.; Runnegar, M.T. Prolonged sublethal exposure to the protein phosphatase inhibitor microcystin-LR results in multiple dose-dependent hepatotoxic effects. Toxicol. Sci. 1998, 44, 87–96.[CrossRef][PubMed]
32. MacKintosh, C.; Beattie, K.A.; Klumpp, S.; Cohen, P.; Codd, G.A. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. FEBS Lett. 1990, 264, 187–192.[CrossRef]
33. Ueno, Y.; Nagata, S.; Tsutsumi, T.; Hasegawa, A.; Watanabe, M.F.; Park, H.D.; Chen, G.C.; Chen, G.; Yu, S.Z. Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis 1996, 17, 1317–1321.[CrossRef][PubMed]
34. Yu, S.Z.; Chen, G. Blue-green algae toxins and liver cancer. Chin. J. Cancer Res. 1994, 6, 9–17.
35. Svircev, Z.; Krstic, S.; Miladinov-Mikov, M.; Baltic, V.; Vidovic, M. Freshwater cyanobacterial blooms and primary liver cancer epidemiological studies in Serbia. J. Environ. Sci. Health 2009, 27, 36–55.[CrossRef][PubMed]
36. Fleming, L.E.; Rivero, C.; Burns, J.; Williams, C.; Bean, J.A.; Shea, K.A.; Stinn, J. Blue green algal (cyanobacterial) toxins, surface drinking water, and liver cancer in Florida. Harmful Algae 2002, 1, 157–168.[CrossRef]
37. Lake Champlain Basin Program. Blue green Algae Monitoring Program. 2000. Available online: http://www.lcbp.org/bgalgae.htm (accessed on 25 October 2011).
38. Bunting, L.; Leavitt, P.R.; Wissel, B.; Laird, K.R.; Cumming, B.F.; St. Amand, A.; Engstrom, D.R. Sudden Ecosystem State Change in Lake Winnipeg, Canada, Caused by Eutrophicationarising from Crop and Livestock Production during the 20th Century; Government of Manitoba: Winnipeg, MB, Canada, 2011; pp. 1–67.
39. Casey, A. Forgotten Lake. Available online: http://www.canadiangeographic.ca/magazine/nd06/feature_lake_winnipeg.asp (accessed on 26 November 2015).
40. Large Lakes and Rivers Forecasting Research Branch. Detroit River-Western Lake Erie Basin Indicator Project. 2009. Available online: http://www.epa.gov/med/grosseile_site/indicators/algae-blooms.html (accessed on 1 November 2011).
41. Nordenstedt, H.; White, D.L.; El-Serag, H.B. The changing pattern of epidemiology in hepatocellular carcinoma. Dig. Liver Dis. 2010, 42 (Suppl. S3), S206–S214.[CrossRef]
42. ESRI. ArcGis 9.3 Geocoding Technology; ESRI 380 New York St.: Redland, CA, USA, 2009.
43. GeoDa. Center for Geospatial Analysis and Computation, A.S.U.; GeoDa: Tempe, AZ, USA, 2006.
44. Kulldorff, M. Satscan 8.0, Software for Spatial and Space-Time Scan Statistics; Information Management Services Inc.: Boston, MA, USA, 2009.
45. Comesana, A.B.; Cerqueiro, J.F.; Medina, R.S. EPIDAT 3.0: Epidemiological Analysis from Tabulated Data; Pan American Health Organization, Conselleria de Sanidade: A Coruña, Spain, 2005.
46. SAS Institute Inc. Sas 9.13 ETL Studio; SAS Institute Inc.: Cary, NC, USA, 2004.
47. Yu, S.Z. Primary prevention of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1995, 10, 674–682.[CrossRef][PubMed]